Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

References & Publications

On This Page

References

  1. Scott MK, Chommanard C, Lu X, Appelgate D, Grenz L, Schneider E, et al. Human Adenovirus Associated with Severe Respiratory Infection, Oregon, USA, 2013—2014. Emerg Infect Dis. 2016 June;22(6):1044-51.
  2. Adenovirus Infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS eds. 2015 Red Book: Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015: 226-8.
  3. Kajon, A.E., et al. Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United StatesJ Infect Dis. 2010;202(1):93-103.
  4. Esposito, D.H., et al. Outbreak of pneumonia associated with emergent human adenovirus serotype 14—Southeast Alaska, 2008J Infect Dis. 2010;202(2):214-22.
  5. Wold WSM, Horwitz MS. Adenoviruses. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia: Lippincott-Raven; 2007: 2395-436.
  6. Foy HM. Adenoviruses. In: Evans A, Kaslow R, eds. Viral Infections in Humans: epidemiology and control. 4th ed. New York: Plenum; 1997:119-38.

Publications

  1. CDC. Human Adenovirus Surveillance — United States, 2003-2016. MMWR Morb Mortal Wkly Rep. 2017;66(39):1039-42.
  2. Killerby ME, Stuckey, MJ, Guendel, I, et al. Notes from the Field: Epidemic Keratoconjunctivitis Outbreak Associated with Human Adenovirus Type 8 — U.S. Virgin Islands, June–November 2016MMWR Morb Mortal Wkly Rep. 2017; 66:811–812.
  3. CDC. Adenovirus-associated epidemic keratoconjunctivitis outbreaks — four states, 2008–2010 . MMWR Morb Mortal Wkly Rep. 62(32);637-41.
  4. CDC. Acute respiratory disease associated with adenovirus serotype 14—four states, 2006–2007. MMWR Morb Mortal Wkly Rep. 56(49);1181-1184.
  5. CDC. Civilian outbreak of adenovirus acute respiratory disease — South Dakota, 1997MMWR Morb Mortal Wkly Rep. 1998;47(27):567-70.
TOP